PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Photodynamic therapy (PDT) using porphyrin precursors is commonly used in dermatology. Evidence indicates that
good clinical outcomes (associated with excellent cosmesis) can be achieved in superficial precancers and basal cell
carcinoma (BCC), however, efficacy appears less favorable for thicker nodular BCC (nBCC) unless multiple PDT
treatment cycles are performed. Enhancement is therefore required if nBCC lesions are to be treated effectively with a
single PDT treatment. The most common technique currently being routinely employed clinically is the use of
aminolevulinic acid (ALA) esters (usually methyl (MAL) or hexyl (HAL)). Standard dermatological PDT employing
these porphyrin precursors already manipulates the normal heme biosynthesis pathway resulting in a temporary
accumulation of the natural photosensitizer, protoporphyrin IX (PpIX). Further manipulation using iron chelating agents
is possible however. In normal and malignant human cells in vitro, the novel iron chelating agent CP94 produced greater
PPIX fluorescence when administered with ALA or MAL than either congener produced alone. CP94 was also
significantly more effective than the clinically established iron chelating agent desferrioxamine (DFO). Topical
application of ALA+CP94 to clinical nBCC lesions was a simple and safe treatment modification which produced a
significant increase in clinical clearance when CP94 was included in the cream.
Alison Curnow,Andrew Pye, andSandra Campbell
"Enhancing protoporphyrin IX-induced PDT", Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 738010 (13 July 2009); https://doi.org/10.1117/12.822241
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Alison Curnow, Andrew Pye, Sandra Campbell, "Enhancing protoporphyrin IX-induced PDT," Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 738010 (13 July 2009); https://doi.org/10.1117/12.822241